Literature DB >> 19755679

Gastric cancer: trastuzumab trial results spur search for other targets.

Karyn Hede.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19755679     DOI： 10.1093/jnci/djp341

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  22 in total

1.  Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers.

Authors:  Meltem Baykara; Mustafa Benekli; Ozgur Ekinci; Sultan Cigdem Irkkan; Halit Karaca; Umut Demirci; Muhammed Bulent Akinci; Olcun Umit Unal; Faysal Dane; Fatma Paksoy Turkoz; Ozan Balakan; Eylem Pinar Eser; Selcuk Cemil Ozturk; Metin Ozkan; Berna Oksuzoglu; Alper Sevinc; Necla Demir; Hakan Harputluoglu; Bulent Yalcin; Ugur Coskun; Aytug Uner; Ahmet Ozet; Suleyman Buyukberber
Journal:  J Gastrointest Surg       Date:  2015-07-16       Impact factor: 3.452

Review 2.  HER2 therapies and gastric cancer: a step forward.

Authors:  Ramon Andrade de Mello; Andrea Marin Marques; António Araújo
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

3.  Geldanamycin induces apoptosis in human gastric carcinomas by affecting multiple oncogenic kinases that have synergic effects with TNF-related apoptosis-inducing ligand.

Authors:  Hui Chen; Liang-Qing Li; Dun Pan
Journal:  Oncol Lett       Date:  2015-10-15       Impact factor: 2.967

4.  Inhibition of gastric tumor growth by a novel Hsp90 inhibitor.

Authors:  Chunwan Lu; Di Liu; Jing Jin; Hemantkumar Deokar; Yi Zhang; John K Buolamwini; Xiaoming Yu; Chunhong Yan; Xiaoguang Chen
Journal:  Biochem Pharmacol       Date:  2013-02-13       Impact factor: 5.858

5.  Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation.

Authors:  Jaeyeon Choi; Ganesan Vaidyanathan; Eftychia Koumarianou; Choong Mo Kang; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2017-09-19       Impact factor: 2.408

Review 6.  Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies.

Authors:  Michael Luis; Ana Tavares; Liliana S Carvalho; Lúcio Lara-Santos; António Araújo; Ramon Andrade de Mello
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

7.  Optical fiber-based in vivo quantification of growth factor receptors.

Authors:  Thommey P Thomas; Yu-Chung Chang; Jing Yong Ye; Alina Kotlyar; Zhengyi Cao; Rameshwer Shukla; Suyang Qin; Theodore B Norris; James R Baker
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

8.  Impact of NPR-A expression in gastric cancer cells.

Authors:  Jia Zhang; Jingkun Qu; Ya Yang; Min Li; Mingxin Zhang; Xiaohai Cui; Jing Zhang; Jiansheng Wang
Journal:  Int J Clin Exp Med       Date:  2014-10-15

9.  Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling.

Authors:  Marek Pruszynski; Eftychia Koumarianou; Ganesan Vaidyanathan; Hilde Revets; Nick Devoogdt; Tony Lahoutte; H Kim Lyerly; Michael R Zalutsky
Journal:  J Nucl Med       Date:  2014-02-27       Impact factor: 10.057

10.  Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody.

Authors:  Marek Pruszynski; Eftychia Koumarianou; Ganesan Vaidyanathan; Hilde Revets; Nick Devoogdt; Tony Lahoutte; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2012-11-15       Impact factor: 2.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.